This study enrolled patients with POAG who participated in the Investigating Glaucoma Progression Study, which is an ongoing prospective study of patients with glaucoma at the glaucoma clinic of Seoul National University Bundang Hospital. All subjects provided written informed consents for their participation. The study protocol was approved by the Institutional Review Board of Seoul National University Bundang Hospital and followed the tenets of the Declaration of Helsinki.
All subjects underwent comprehensive ophthalmic examinations, which included best-corrected visual acuity assessments, Goldmann applanation tonometry, refraction tests, slit-lamp biomicroscopy, gonioscopy, stereo disc photography, red-free fundus photography (using an EOS-D60 digital camera; Canon, Tokyo Japan), measurement of peripapillary RNFL thickness, enhanced depth-imaging scanning of the ONH using spectral-domain OCT (SPECTRALIS; Heidelberg Engineering, Heidelberg, Germany), swept-source OCT and OCTA of the ONH and peripapillary area (DRI OCT Triton; Topcon, Tokyo, Japan), and standard automated perimetry (Humphrey Field Analyzer II 750, 24-2 Swedish Interactive Threshold Algorithm; Carl Zeiss Meditec, Dublin, CA, USA). Other ophthalmic examinations included measurements of corneal curvature (KR-800; Topcon), central corneal thickness, and axial length (IOL Master 5; Carl Zeiss Meditec).
Untreated IOP was defined as that measured before the initiation of ocular hypotensive treatment or as identified in the referral notes. Diurnal variation in patients with an untreated IOP of <21 mm Hg was measured every 2 hours from 9 AM to 5 PM, with the mean of the five measurements considered the untreated IOP for that patient. In patients with an untreated IOP of >21 mm Hg, IOP was measured twice before IOP-lowering medication was administered, with the mean of the two measurements considered the untreated IOP for that patient. Patients who were undergoing treatment with ocular hypotensive medication at the time of the initial visit received the diurnal variation measurements after a 4-week washout period.
Systolic and diastolic blood pressures (BPs) were measured using a digital automatic BP monitor (Omron HEM-770A; Omron, Kyoto, Japan). The mean arterial pressure (MAP) was calculated as diastolic BP + 1/3(systolic BP – diastolic BP), and the mean ocular perfusion pressure was calculated as 2/3(MAP – IOP) at the time of OCTA being performed.
POAG was defined as the presence of an open iridocorneal angle and a glaucomatous VF defect, with signs of glaucomatous optic nerve damage (i.e., neuroretinal rim thinning or notching or an RNFL defect). A glaucomatous VF defect was defined as a defect that met one or more of the following criteria: (1) outside normal limits on a Glaucoma Hemifield Test; (2) three abnormal points with a <5% probability of being normal and one abnormal point with a <1% probability of being normal according to pattern deviation; or (3) a pattern standard deviation (PSD) of probability < 5% confirmed on two consecutive reliable tests. Reliability in these tests was defined as fixation loss, false-positive, and false-negative rates of 20%, 15%, and 25%, respectively.
Considering that the normal morphological characteristics of the ONH
23–25 and thickness profiles of the PC
26,27 differed between the superior and inferior sectors, and that most occurrences of MvD-PC and MvD-LC were located in the inferior sectors,
2,10,19 only eyes with ONH damage to the inferior sectors were included in the present study.
Eyes were excluded if they had a best-corrected visual acuity worse than 20/40, a spherical equivalent of <−9.0 D or >+3.0 D, a cylinder correction of <−3.0 D or >+3.0 D, a history of intraocular surgery with the exception of uneventful cataract surgery, retinal diseases (e.g., diabetic retinopathy, retinal vessel occlusion, retinoschisis), or neurological diseases (e.g., pituitary tumor). Eyes with γ-zone parapapillary atrophy (PPA)
28 were also excluded because the microstructure underlying MvD-PC differs between PPA in the β- and γ-zones, with MvD-PC in the latter consisting only of border tissue, not choroid, which indicates a different pathomechanism.
29 When a subject had two eligible eyes, one was randomly selected for inclusion in the study.